Medical genomic can be defined as the utilization of genome-based information in the making of clinical decisions. A broader concept, personalized medicine, is often used to describe the models of healthcare that emphasize the application of an individual’s unique environmental, genomic, genetic, and clinical information to the treatment and prevention of diseases (Brunicardi; Offit). In their practice, doctors combine the results of patient data, which include individual genomic information, family history, medical history, conventional test results, and symptoms. The combination of the data allows the physicians to diagnose diseases accurately and personalize treatment strategies (Alzu’bi et al.). ...
Essays on Kinases
2 samples on this topic
The array of written assignments you might get while studying Kinases is stunning. If some are too challenging, an expertly crafted sample Kinases piece on a related subject might lead you out of a deadlock. This is when you will definitely appreciate WowEssays.com ever-expanding collection of Kinases essay samples meant to ignite your writing enthusiasm.
Our directory of free college paper samples showcases the most bright instances of excellent writing on Kinases and related topics. Not only can they help you develop an interesting and fresh topic, but also demonstrate the effective use of the best Kinases writing practices and content organization techniques. Also, keep in mind that you can use them as a trove of authoritative sources and factual or statistical information processed by real masters of their craft with solid academic experience in the Kinases field.
Alternatively, you can take advantage of effective write my essay assistance, when our experts deliver a unique model essay on Kinases tailored to your individual instructions!
Abstract
Cancer of the lungs is among the leading causes of cancer in the world. It has two forms; small cell lung cancer (SCLC), and non-small-cell lung cancer (NSCLC). NSCLC constitutes about 85% of cases of lung cancer. Epidermal growth factor receptor (EGFR) and its mutations are found to have an important role in this cancer. Therefore, EGFR tyrosine kinase inhibitors (TKIs) can work effectively against NSCLC. Gefitinib, which is a first generation TKI, and afatinib, which is a second-generation TKI, are effective as a first-line therapy for advanced NSCLC. Erlotinib is effective as a second-line therapy for advanced NSCLC. ...